Renal Cancer - Results from #240

The Current Application and Future Potential of Artificial Intelligence in Renal Cancer. July 24, 2024

A comparative analysis of fear of cancer recurrence in patients with small renal masses: Active surveillance versus cryoablation. July 24, 2024

Socioeconomic and Demographic Disparities in Immunotherapy Utilization for Advanced Kidney and Bladder Cancer. July 23, 2024

Concomitant Administration of VEGFR Tyrosine Kinase and Proton Pump Inhibitors May Impair Clinical Outcome of Patients With Metastatic Renal Cancer. July 23, 2024

Frequency and clinicopathologic features of renal low-grade oncocytic tumour and eosinophilic vacuolated tumour: reclassification of 605 eosinophilic tumours including patients managed with active surveillance. July 23, 2024

Sodium levels and immunotherapy efficacy in mRCC patients with bone metastases: sub analysis of Meet-Uro 15 study. July 23, 2024

Stereotactic Body Radiotherapy for Primary Renal Cell Carcinoma: A Case-Based Radiosurgery Society Practice Guide. July 22, 2024

Metastatic renal cell carcinoma with occult primary: a multicenter prospective cohort. July 22, 2024

Portal Venous Thrombosis after Percutaneous Cryoablation for Renal Cell Carcinoma. July 22, 2024

Renal cell carcinoma July 19, 2024

Prevalence of diabetes and hospitalization due to poor glycemic control in people with bladder cancer or renal cell carcinoma in Sweden. July 19, 2024

Imaging modalities for characterising T1 renal tumours: A systematic review and meta-analysis of diagnostic accuracy. July 19, 2024

AVEO Oncology, an LG Chem company, Announces Phase 3 Renal Cell Carcinoma Clinical Trial (TiNivo-2) Results July 18, 2024

Pathological concordance rate and outcomes by subtype in advanced papillary renal cell carcinoma. July 18, 2024

Association of circulating tumor DNA with patient prognosis in surgically resected renal cell carcinoma. July 18, 2024

Whole genome sequencing refines stratification and therapy of patients with clear cell renal cell carcinoma. July 17, 2024

Generation and Characterization of Ex Vivo Expanded Tumor-infiltrating Lymphocytes From Renal Cell Carcinoma Tumors for Adoptive Cell Therapy. July 17, 2024

Sarcoidosis-like reactions in metastatic renal cell carcinoma patients treated with immune-based combinations. July 16, 2024

Molecular analysis of primary and metastatic sites in patients with renal cell carcinoma. July 16, 2024

Failure of the PD-1 Blocking Agent Pembrolizumab to Benefit a Patient with Renal Squamous Cell Cancer. July 16, 2024

Page 13 of 456